Antigen-adjuvant formulation and characterization studies
Ended Awarded Last action
- Contract number
- 75N93019F00270
- Awardee
-
International Aids Vaccine Initiative Inc. UEI ZEJBC8JQM3P5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $978,729
Award facts
- Opportunity
-
- NIHAI2014013 Solicitation number
- Contract value 100% obligated
- $978,729.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- New York, NY 10004, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$93,897 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,072,626 |
About this award
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global not-for-profit organization. The $978,729.00 cost-plus-fixed-fee award supports "ANTIGEN-ADJUVANT FORMULATION AND CHARACTERIZATION STUDIES" as part of NIAID's PROCESS AND ANALYTICAL SUPPORT FOR DEVELOPMENT OF HIV VACCINES program. IAVI, the prime contractor, is providing a range of research, development, manufacturing, and analytical services to advance HIV vaccine candidates through preclinical and clinical testing. This work includes process development, testing, cGMP manufacturing, regulatory support, and other activities. IAVI has subcontracted a portion of the effort to the University of Kansas Center for Research Inc., a non-profit academic institution. There was no set-aside designation used for this award. IAVI holds multiple Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with NIAID to provide these types of vaccine development services across various infectious disease programs.
Quick answers
Who was awarded contract 75N93019F00270?
75N93019F00270 was awarded to International Aids Vaccine Initiative Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 30, 2019.
How much is contract 75N93019F00270 worth?
The government has obligated $978,729 on 75N93019F00270.
Is contract 75N93019F00270 an order under another contract?
Yes. 75N93019F00270 is a delivery order under HHSN272201600011I, an indefinite delivery contract.
Was contract 75N93019F00270 competed?
The extent of competition for 75N93019F00270 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award